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Background
QX222 is a quaternary amine analogue of lidocaine,
which, unlike lidocaine, is permanently charged. Lido-
caine has its binding site in the internal vestibule of the
voltage-gated sodium channel. Due to the hydrophobic
nature of its uncharged form, lidocaine reaches the
binding site by passing through the membrane, QX222
can reach this binding site only by a hydrophilic path-
way, presumably through the channel protein. However,
such a pathway has been reported only in the heart-type
sodium channel (NaV1.5) and some mutants of other
sodium channels. Notably, mutations at site 1575 in the
skeletal muscle-type sodium channel (NaV1.4) open an
access pathway from the external side. In this study we
tested the properties of QX222 block on the mutant
I1575E.
Methods
All measurements were done in tsA201 cells transiently
transfected with the NaV1.4 sodium channel a subunit,
cotransfected with b1 sodium channel subunit. Currents
were recorded by patch-clamp technique in whole-cell
configuration.
Results
Both 500 μM lidocaine and 500 μM QX222 shifted the
half-point of steady-state slow inactivation to hyperpo-
larized potentials in I1575E if applied from the extracel-
lular side. However, only lidocaine significantly shifted
the half-point of steady-state fast inactivation. Intracellu-
lar application of QX222 resulted in a quick block of
sodium current, indicating that the drug entered the
channel, but the hyperpolarizing shift of steady-state fast
inactivation was still not present. In addition, with intra-
cellular application of QX222, the strong hyperpolariz-
ing shift in steady-state slow inactivation disappeared.
Conclusions
These results suggest that the binding site for use-
dependent block is in the inner vestibule of the channel,
that fast inactivation is modulated only by the hydro-
phobic form of local anaesthetics, and that the binding
site for modulation of slow inactivation is only accessi-
ble form the extracellular side of the channel.
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